| Sodium Chloride 0.18% w/v and Glucose 4.0% w/v Intravenous Infusion BP, (Viaflo Container) PA2299/008/005 |
Sodium chloride, Anhydrous glucose |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride 0.3% w/v and Glucose 3.3% w/v Solution for Infusion BP PA2299/008/004 |
Sodium chloride, Glucose |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride 0.45% w/v and Glucose 2.5% w/v Solution for Infusion BP PA2299/008/003 |
Sodium chloride, Glucose |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride 0.45% w/v and Glucose 5.0% w/v Solution for Infusion BP PA2299/008/001 |
Sodium chloride, Glucose |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride 0.45% w/v Solution for Infusion PA2299/002/002 |
Sodium chloride |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride 0.9% w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) PA2299/008/002 |
Sodium chloride, Glucose |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride 0.9% w/v Intravenous Infusion BP PA2299/002/001 |
Sodium chloride |
Baxter Holding B.V. |
Marketed |
| Sodium Chloride Intravenous Infusion BP 0.9% w/v (viaflex container) PA2299/002/003 |
Sodium chloride |
Baxter Holding B.V. |
Marketed |
| Sugammadex 100 mg/ml Solution for Injection PA2299/058/001 |
Sugammadex sodium |
Baxter Holding B.V. |
Not marketed |
| Suprane Inhalation vapour, solution PA2299/023/001 |
Desflurane |
Baxter Holding B.V. |
Marketed |
| TISSEEL Lyo Powder and Solvent for Sealant PA2299/025/002 |
Human fibrinogen, Aprotinin, Human thrombin, Human factor xiii, Calcium chloride |
Baxter Holding B.V. |
Marketed |
| TISSEEL Ready to use Solutions for Sealant PA2299/025/001 |
Human fibrinogen, Aprotinin, Human factor xiii, Human thrombin, Calcium chloride |
Baxter Holding B.V. |
Marketed |
| Tranexamic acid 100 mg/mL solution for injection/infusion PA2299/048/001 |
TRANEXAMIC ACID PH. EUR. |
Baxter Holding B.V. |
Not marketed |
| TRIOMEL 12 g/l nitrogen 950 kcal/l with electrolytes, emulsion for infusion PA2299/043/007 |
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine |
Baxter Holding B.V. |
Marketed |
| TRIOMEL 12 g/l nitrogen 950 kcal/l, emulsion for infusion PA2299/043/008 |
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine |
Baxter Holding B.V. |
Marketed |
| Triomel 5g/L nitrogen 990kcal/L with electrolytes, emulsion for infusion PA2299/029/002 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid |
Baxter Holding B.V. |
Marketed |
| Triomel 7g/L nitrogen 1140kcal/L emulsion for infusion PA2299/029/004 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid |
Baxter Holding B.V. |
Marketed |
| Triomel 7g/L nitrogen 1140kcal/L with electrolytes emulsion for infusion PA2299/029/003 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid |
Baxter Holding B.V. |
Marketed |
| Triomel 9g/L nitrogen 1070kcal/L emulsion for infusion PA2299/029/006 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid |
Baxter Holding B.V. |
Marketed |
| Triomel 9g/L nitrogen 1070kcal/L with electrolytes emulsion for infusion PA2299/029/005 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid |
Baxter Holding B.V. |
Marketed |
| Triomel Peripheral 4 g/L nitrogen 700 kcal/L with electrolytes emulsion for infusion PA2299/029/001 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid |
Baxter Holding B.V. |
Marketed |
| Uromitexan 100mg/ml Solution for Injection or Infusion PA2299/024/001 |
Mesna |
Baxter Holding B.V. |
Marketed |
| Uromitexan tablets 400 mg PA2299/024/002 |
Mesna |
Baxter Holding B.V. |
Marketed |
| Uromitexan Tablets 600mg PA2299/024/003 |
Mesna |
Baxter Holding B.V. |
Marketed |
| Water for Injections Ph. Eur., viaflo container PA2299/013/001 |
Water for injection |
Baxter Holding B.V. |
Marketed |